Chargement en cours...

Conditional approval of cancer drugs in Canada: accountability and impact on public funding

BACKGROUND: We examined how conditional market approval of cancer pharmaceuticals by Health Canada (hc) affects public funding recommendations by the pan-Canadian Oncology Review (pcodr). We were also interested to see how often hc conditions are enforced. METHODS: Health Canada and pcodr databases...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Curr Oncol
Auteurs principaux: Andersen, S.K., Penner, N., Chambers, A., Trudeau, M.E., Chan, K.K.W., Cheung, M.C.
Format: Artigo
Langue:Inglês
Publié: Multimed Inc. 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380633/
https://ncbi.nlm.nih.gov/pubmed/30853815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4397
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!